Literature DB >> 20661663

Knockdown of BMI-1 causes cell-cycle arrest and derepresses p16INK4a, HOXA9 and HOXC13 mRNA expression in HeLa cells.

Fenghua Chen1, Yirong Li, Lin Wang, Lihua Hu.   

Abstract

The human oncogene B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) is a member of the mammalian Polycomb group family. The overexpression of BMI-1 is associated with human malignancies. In this study, the effects of knockdown of BMI-1 by shRNA-mediated RNA interference on cell cycle and possible downstream targets in human cervical adenocarcinoma HeLa cells were investigated. As a result, when the shRNA plasmid was stably introduced into the cell line, the mRNA and protein of BMI-1 were specifically down-regulated, and the cells increased in the phase of G1 and cells in S phase significantly decreased by flow cytometric analysis; the knockdown of BMI-1 expression could lead to significant up-regulation of p16INK4a, HOXA9 and HOXC13 mRNA expression, but hTERT and HOXB4 mRNA expression did not change significantly. In conclusion, RNAi-mediated knockdown of BMI-1 expression can induce cell-cycle arrest and up-regulate p16INK4a, HOXA9 and HOXC13 in HeLa cells. Our results suggest that targeting BMI-1 might be a therapeutic potential for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661663     DOI: 10.1007/s12032-010-9634-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

3.  The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression.

Authors:  N M van der Lugt; M Alkema; A Berns; J Deschamps
Journal:  Mech Dev       Date:  1996-08       Impact factor: 1.882

4.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.

Authors:  Julie Lessard; Guy Sauvageau
Journal:  Nature       Date:  2003-04-20       Impact factor: 49.962

5.  Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.

Authors:  Andrei Kuzmichev; Thomas Jenuwein; Paul Tempst; Danny Reinberg
Journal:  Mol Cell       Date:  2004-04-23       Impact factor: 17.970

6.  SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.

Authors:  Ru Cao; Yi Zhang
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

7.  Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.

Authors:  Carly Leung; Merel Lingbeek; Olga Shakhova; James Liu; Ellen Tanger; Parvin Saremaslani; Maarten Van Lohuizen; Silvia Marino
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

8.  Polycomb group proteins and heritable silencing of Drosophila Hox genes.

Authors:  D Beuchle; G Struhl; J Müller
Journal:  Development       Date:  2001-03       Impact factor: 6.868

9.  Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression.

Authors:  T Akasaka; M van Lohuizen; N van der Lugt; Y Mizutani-Koseki; M Kanno; M Taniguchi; M Vidal; M Alkema; A Berns; H Koseki
Journal:  Development       Date:  2001-05       Impact factor: 6.868

10.  The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.

Authors:  S Vonlanthen; J Heighway; H J Altermatt; M Gugger; A Kappeler; M M Borner; M van Lohuizen; D C Betticher
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

View more
  8 in total

1.  HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.

Authors:  Yu Yao; Jing Luo; Qi Sun; Ting Xu; Siqing Sun; Meili Chen; Xin Lin; Qiuping Qian; Yu Zhang; Lin Cao; Po Zhang; Yong Lin
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

2.  HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3.

Authors:  Jing Luo; Zhongqiu Wang; Jianfeng Huang; Yu Yao; Qi Sun; Jie Wang; Yi Shen; Lin Xu; Binhui Ren
Journal:  Cancer Sci       Date:  2017-12-20       Impact factor: 6.716

3.  PTEN Mediates Activation of Core Clock Protein BMAL1 and Accumulation of Epidermal Stem Cells.

Authors:  Chiara Zagni; Luciana O Almeida; Tarek Balan; Marco T Martins; Luciana K Rosselli-Murai; Petros Papagerakis; Rogerio M Castilho; Cristiane H Squarize
Journal:  Stem Cell Reports       Date:  2017-06-08       Impact factor: 7.765

4.  Oncogenic and tumor suppressor function of MEIS and associated factors.

Authors:  Birkan Gİrgİn; Medine KaradaĞ-Alpaslan; Fatih KocabaŞ
Journal:  Turk J Biol       Date:  2020-12-14

Review 5.  The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies.

Authors:  Jie Xu; Lin Li; Pengfei Shi; Hongjuan Cui; Liqun Yang
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 6.  Biochemical and functional interactions of human papillomavirus proteins with polycomb group proteins.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Viruses       Date:  2013-05-14       Impact factor: 5.048

7.  Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13.

Authors:  Ming Yu; Salma Al-Dallal; Latifa Al-Haj; Shiraj Panjwani; Akina S McCartney; Sarah M Edwards; Pooja Manjunath; Catherine Walker; Alexander Awgulewitsch; Kathryn E Hentges
Journal:  Genesis       Date:  2016-08-29       Impact factor: 2.487

8.  Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1.

Authors:  Gui-Feng Liu; Shu-Hua Zhang; Xue-Feng Li; Li-Yan Cao; Zhan-Zhao Fu; Shao-Nan Yu
Journal:  Oncotarget       Date:  2017-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.